Is hepatitis E virus an emerging problem in industrialized countries?

Hepatology

Volumn 62, Issue 6, 2015, Pages 1883-1892

  Sayed, Ibrahim M ^a,b   Vercouter, Ann Sofie ^a   Abdelwahab, Sayed F ^c,d   Vercauteren, Koen ^a   Meuleman, Philip ^a  

^a GHENT UNIVERSITY HOSPITAL   (Belgium)

^b Assiut University Faculty of Medicine   (Egypt)

^c Minia University   (Egypt)

^d TAIF UNIVERSITY   (Saudi Arabia)

Author keywords

[No Author keywords available]

Indexed keywords

ACUTE DISEASE; CHRONIC DISEASE; COMMUNICABLE DISEASE; DEVELOPED COUNTRY; EUROPE; FEMALE; HEPATITIS E; HEPATITIS E VIRUS; HUMAN; MALE; TRANSMISSION; UNITED STATES;

ACUTE DISEASE; CHRONIC DISEASE; COMMUNICABLE DISEASES, EMERGING; DEVELOPED COUNTRIES; EUROPE; FEMALE; HEPATITIS E; HEPATITIS E VIRUS; HUMANS; MALE; UNITED STATES;

EID: 84955203553     PISSN: 02709139     EISSN: 15273350     Source Type: Journal    
DOI: 10.1002/hep.27990     Document Type: Review

References (93)

1. Wong D, Purcell R, Mandyam Ammanjee S, Rama Prasad S, Pavri K. Epidemic and endemic hepatitis in India-Evidence for non-A, non-B hepatitis virus aetiology. Lancet 1980;316:876-879.
2. Reyes GR, Purdy MA, Kim JP, Luk KC, Young LM, Fry KE, Bradley DW. Isolation of a cDNA from the virus responsible for enterically transmitted non-A, non-B hepatitis. Science 1990;247:1335-1339.
3. Tam AW, Smith MM, Guerra ME, Huang CC, Bradley DW, Fry KE, Reyes GR. Hepatitis E virus (HEV): molecular cloning and sequencing of the full-length viral genome. Virology 1991;185:120-131.
4. Sayed IM, Vercauteren K, Abdelwahab SF, Meuleman P. The emergence of HEV in Europe. Fut Virol 2015;10:763-778.
5. Tohme RA, Drobeniuc J, Sanchez R, Heseltine G, Alsip B, Kamili S, et al. Acute hepatitis associated with autochthonous hepatitis E virus infection-San Antonio, Texas, 2009. Clin Infect Dis 2011;53:793-796.
6. Teshale EH, Denniston MM, Drobeniuc J, Kamili S, Teo CG, Holmberg SD. Decline in hepatitis E virus antibody prevalence in the United States from 1988-1994 to 2009-2010. J Infect Dis 2015;211:366-373.
7. Holla RP, Ahmad I, Ahmad Z, Jameel S. Molecular virology of hepatitis E virus. Semin Liver Dis 2013;33:3-14.
8. Shrestha MP, Scott RM, Joshi DM, Mammen MP, Thapa GB, Thapa N, et al. Safety and efficacy of a recombinant hepatitis E vaccine. N Engl J Med 2007;356:895-903.
9. Zhu FC, Zhang J, Zhang XF, Zhou C, Wang ZZ, Huang SJ, et al. Efficacy and safety of a recombinant hepatitis E vaccine in healthy adults: a large-scale, randomised, double-blind placebo-controlled, phase 3 trial. Lancet 2010;376:895-902.
10. Purdy MA, Smith DB, Simmonds P, Emerson SU, Harrison T, Meng X-J, Okamoto H, Van der Poel WHM, Jameel S; Hepeviridae Study Group. New Classification Scheme for Hepeviridae. Available at: http://www.ictvonline.org/proposals/2014.008a-hV.A.v6.Hepeviridae.pdf.
11. Smith DB, Simmonds P, Jameel S, Emerson SU, Harrison TJ, Meng XJ, et al. Consensus proposals for classification of the family Hepeviridae. J Gen Virol 2014;95:2223-2232.
12. Lu L, Li CH, Hagedorn CH. Phylogenetic analysis of global hepatitis E virus sequences: genetic diversity, subtypes and zoonosis. Rev Med Virol 2006;16:5-36.
13. Yugo DM, Meng XJ. Hepatitis E virus: foodborne, waterborne and zoonotic transmission. Int J Environ Res Public Health 2013;10:4507-4533.
14. Meng XJ. Zoonotic and foodborne transmission of hepatitis E virus. Semin Liver Dis 2013;33:41-49.
15. Kokkinos P, Kozyra I, Lazic S, Bouwknegt M, Rutjes S, Willems K, et al. Harmonised investigation of the occurrence of human enteric viruses in the leafy green vegetable supply chain in three European countries. Food Environ Virol 2012;4:179-191.
16. Brassard J, Gagne MJ, Genereux M, Cote C. Detection of human food-borne and zoonotic viruses on irrigated, field-grown strawberries. Appl Environ Microbiol 2012;78:3763-3766.
17. Krain LJ, Atwell JE, Nelson KE, Labrique AB. Fetal and neonatal health consequences of vertically transmitted hepatitis E virus infection. Am J Trop Med Hyg 2014;90:365-370.
18. Haim-Boukobza S, Ferey MP, Vetillard AL, Jeblaoui A, Pelissier E, Pelletier G, et al. Transfusion-transmitted hepatitis E in a misleading context of autoimmunity and drug-induced toxicity. J Hepatol 2012;57:1374-1378.
19. Huzly D, Umhau M, Bettinger D, Cathomen T, Emmerich F, Hasselblatt P, et al. Transfusion-transmitted hepatitis E in Germany, 2013. Euro Surveill 2014;19. pii: 20812.
20. Hewitt PE, Ijaz S, Brailsford SR, Brett R, Dicks S, Haywood B, et al. Hepatitis E virus in blood components: a prevalence and transmission study in southeast England. Lancet 2014;384:1766-1773.
21. Andonov A, Rock G, Lin L, Borlang J, Hooper J, Grudeski E, Wu J. Serological and molecular evidence of a plausible transmission of hepatitis E virus through pooled plasma. Vox Sang 2014;107:213-219.
22. Matsubayashi K, Kang JH, Sakata H, Takahashi K, Shindo M, Kato M, et al. A case of transfusion-transmitted hepatitis E caused by blood from a donor infected with hepatitis E virus via zoonotic food-borne route. Transfusion 2008;48:1368-1375.
23. Engle RE, Bukh J, Alter HJ, Emerson SU, Trenbeath JL, Nguyen HT, et al. Transfusion-associated hepatitis before the screening of blood for hepatitis risk factors. Transfusion 2014;54:2833-2841.
24. Xu C, Wang RY, Schechterly CA, Ge S, Shih JW, Xia NS, et al. An assessment of hepatitis E virus (HEV) in US blood donors and recipients: no detectable HEV RNA in 1939 donors tested and no evidence for HEV transmission to 362 prospectively followed recipients. Transfusion 2013;53:2505-2511.
25. Rein DB, Stevens GA, Theaker J, Wittenborn JS, Wiersma ST. The global burden of hepatitis E virus genotypes 1 and 2 in 2005. Hepatology 2012;55:988-997.
26. Drobeniuc J, Favorov MO, Shapiro CN, Bell BP, Mast EE, Dadu A, et al. Hepatitis E virus antibody prevalence among persons who work with swine. J Infect Dis 2001;184:1594-1597.
27. Feagins AR, Opriessnig T, Guenette DK, Halbur PG, Meng XJ. Detection and characterization of infectious Hepatitis E virus from commercial pig livers sold in local grocery stores in the USA. J Gen Virol 2007;88:912-917.
28. Davern TJ, Chalasani N, Fontana RJ, Hayashi PH, Protiva P, Kleiner DE, et al.; Drug-Induced Liver Injury Network (DILIN). Acute hepatitis E infection accounts for some cases of suspected drug-induced liver injury. Gastroenterology 2011;141:1665-1672.e1-9.
29. Meng XJ, Wiseman B, Elvinger F, Guenette DK, Toth TE, Engle RE, et al. Prevalence of antibodies to hepatitis E virus in veterinarians working with swine and in normal blood donors in the United States and other countries. J Clin Microbiol 2002;40:117-122.
30. Kuniholm MH, Purcell RH, McQuillan GM, Engle RE, Wasley A, Nelson KE. Epidemiology of hepatitis E virus in the United States: results from the Third National Health and Nutrition Examination Survey, 1988-1994. J Infect Dis 2009;200:48-56.
31. Wedemeyer H, Pischke S, Manns MP. Pathogenesis and treatment of hepatitis e virus infection. Gastroenterology 2012;142:1388-1397.e1
32. Khuroo MS, Kamili S. Aetiology, clinical course and outcome of sporadic acute viral hepatitis in pregnancy. J Viral Hepat 2003;10:61-69.
33. Navaneethan U, Al Mohajer M, Shata MT. Hepatitis E and pregnancy: understanding the pathogenesis. Liver Int 2008;28:1190-1199.
34. Bose PD, Das BC, Kumar A, Gondal R, Kumar D, Kar P. High viral load and deregulation of the progesterone receptor signaling pathway: association with hepatitis E-related poor pregnancy outcome. J Hepatol 2011;54:1107-1113.
35. Cheng SH, Mai L, Zhu FQ, Pan XF, Sun HX, Cao H, et al. Influence of chronic HBV infection on superimposed acute hepatitis E. World J Gastroenterol 2013;19:5904-5909.
36. Kumar M, Sharma BC, Sarin SK. Hepatitis E virus as an etiology of acute exacerbation of previously unrecognized asymptomatic patients with hepatitis B virus-related chronic liver disease. J Gastroenterol Hepatol 2008;23:883-887.
37. Aherfi S, Borentain P, Raissouni F, Le Goffic A, Guisset M, Renou C, et al. Liver transplantation for acute liver failure related to autochthonous genotype 3 hepatitis E virus infection. Clin Res Hepatol Gastroenterol 2014;38:24-31.
38. Festa S, Garbuglia AR, Baccini F, Panzuto F, Capobianchi MR, Santino I, et al. Acute fulminant hepatitis E virus genotype 3e infection: description of the first case in Europe. Scand J Infect Dis 2014;46:727-731.
39. Haagsma EB, van den Berg AP, Porte RJ, Benne CA, Vennema H, Reimerink JH, Koopmans MP. Chronic hepatitis E virus infection in liver transplant recipients. Liver Transpl 2008;14:547-553.
40. Kenfak-Foguena A, Schoni-Affolter F, Burgisser P, Witteck A, Darling KE, Kovari H, et al. Hepatitis E virus seroprevalence and chronic infections in patients with HIV, Switzerland. Emerg Infect Dis 2011;17:1074-1078.
41. Kamar N, Selves J, Mansuy JM, Ouezzani L, Peron JM, Guitard J, et al. Hepatitis E virus and chronic hepatitis in organ-transplant recipients. N Engl J Med 2008;358:811-817.
42. Renou C, Lafeuillade A, Cadranel JF, Pavio N, Pariente A, Allegre T, et al. Hepatitis E virus in HIV-infected patients. AIDS 2010;24:1493-1499.
43. Pfefferle S, Frickmann H, Gabriel M, Schmitz N, Gunther S, Schmidt-Chanasit J. Fatal course of an autochthonous hepatitis E virus infection in a patient with leukemia in Germany. Infection 2012;40:451-454.
44. Grewal P, Kamili S, Motamed D. Chronic hepatitis E in an immunocompetent patient: a case report. Hepatology 2014;59:347-348.
45. Honer zu Siederdissen C, Pischke S, Schlue J, Deterding K, Hellms T, Schuler-Luttmann S, et al. Chronic hepatitis E virus infection beyond transplantation or human immunodeficiency virus infection. Hepatology 2014;60:1112-1113.
46. Suneetha PV, Pischke S, Schlaphoff V, Grabowski J, Fytili P, Gronert A, Bremer B, et al. Hepatitis E virus (HEV)-specific T-cell responses are associated with control of HEV infection. Hepatology 2012;55:695-708.
47. Dalton HR, Bendall RP, Keane FE, Tedder RS, Ijaz S. Persistent carriage of hepatitis E virus in patients with HIV infection. N Engl J Med 2009;361:1025-1027.
48. Neukam K, Barreiro P, Macias J, Avellon A, Cifuentes C, Martin-Carbonero L, et al. Chronic hepatitis E in HIV patients: rapid progression to cirrhosis and response to oral ribavirin. Clin Infect Dis 2013;57:465-468.
49. Kaba M, Richet H, Ravaux I, Moreau J, Poizot-Martin I, Motte A, et al. Hepatitis E virus infection in patients infected with the human immunodeficiency virus. J Med Virol 2011;83:1704-1716.
50. Pineda JA, Cifuentes C, Parra M, Merchante N, Perez-Navarro E, Rivero-Juarez A, et al. Incidence and natural history of hepatitis E virus coinfection among HIV-infected patients. AIDS 2014;28:1931-1937.
51. Pischke S, Suneetha PV, Baechlein C, Barg-Hock H, Heim A, Kamar N, et al. Hepatitis E virus infection as a cause of graft hepatitis in liver transplant recipients. Liver Transpl 2010;16:74-82.
52. Legrand-Abravanel F, Kamar N, Sandres-Saune K, Lhomme S, Mansuy JM, Muscari F, et al. Hepatitis E virus infection without reactivation in solid-organ transplant recipients, France. Emerg Infect Dis 2011;17:30-37.
53. Pas SD, de Man RA, Mulders C, Balk AH, van Hal PT, Weimar W, et al. Hepatitis E virus infection among solid organ transplant recipients, the Netherlands. Emerg Infect Dis 2012;18:869-872.
54. Buffaz C, Scholtes C, Dron AG, Chevallier-Queyron P, Ritter J, Andre P, Ramiere C. Hepatitis E in liver transplant recipients in the Rhone-Alpes region in France. Eur J Clin Microbiol Infect Dis 2014;33:1037-1043.
55. Kamar N, Garrouste C, Haagsma EB, Garrigue V, Pischke S, Chauvet C, et al. Factors associated with chronic hepatitis in patients with hepatitis E virus infection who have received solid organ transplants. Gastroenterology 2011;140:1481-1489.
56. Lens S, Mensa L, Gambato M, Gonzalez P, Torras X, Soriano G, et al. HEV infection in two referral centers in Spain; epidemiology and clinical outcomes. J Clin Virol 2015;63:76-80.
57. Moal V, Legris T, Burtey S, Morange S, Purgus R, Dussol B, et al. Infection with hepatitis E virus in kidney transplant recipients in southeastern France. J Med Virol 2013;85:462-471.
58. Pischke S, Greer M, Hardtke S, Bremer B, Gisa A, Lehmann P, et al. Course and treatment of chronic hepatitis E virus infection in lung transplant recipients. Transpl Infect Dis 2014;16:333-339.
59. Pischke S, Stiefel P, Franz B, Bremer B, Suneetha PV, Heim A, et al. Chronic hepatitis E in heart transplant recipients. Am J Transplant 2012;12:3128-3133.
60. Koning L, Pas SD, de Man RA, Balk AH, de Knegt RJ, Ten Kate FJ, et al. Clinical implications of chronic hepatitis E virus infection in heart transplant recipients. J Heart Lung Transplant 2013;32:78-85.
61. Versluis J, Pas SD, Agteresch HJ, de Man RA, Maaskant J, Schipper ME, et al. Hepatitis E virus: an underestimated opportunistic pathogen in recipients of allogeneic hematopoietic stem cell transplantation. Blood 2013;122:1079-1086.
62. Halac U, Beland K, Lapierre P, Patey N, Ward P, Brassard J, et al. Chronic hepatitis E infection in children with liver transplantation. Gut 2012;61:597-603.
63. Halac U, Beland K, Lapierre P, Patey N, Ward P, Brassard J, et al. Cirrhosis due to chronic hepatitis E infection in a child post-bone marrow transplant. J Pediatr 2012;160:871-874.e1.
64. Im GY, Sehgal V, Ward SC. A case of undulating fevers and elevated liver tests after pancreas-kidney transplantation. Semin Liver Dis 2013;33:89-93.
65. Te HS, Drobeniuc J, Kamili S, Dong C, Hart J, Sharapov UM. Hepatitis E virus infection in a liver transplant recipient in the United States: a case report. Transplant Proc 2013;45:810-813.
66. Drobeniuc J, Greene-Montfort T, Le NT, Mixson-Hayden TR, Ganova-Raeva L, Dong C, et al. Laboratory-based surveillance for hepatitis E virus infection, United States, 2005-2012. Emerg Infect Dis 2013;19:218-222.
67. Terrault N, Engle RE, Dodge JL, Freise C, Sherker AH, Farci P, Purcell RH. Hepatitis E virus (HEV) infection is rare cause of hepatitis among US liver transplant recipients. Hepatology 2014;60:534A.
68. Sue PK, Pisanic N, Heaney CD, Nelson K, Schwarz KB, Valsamakis A, et al. Characteristics of post transplantation hepatitis E virus infection among solid organ transplant recipients at a North American transplant center. Hepatology 2014;60:535A.
69. Kamar N, Weclawiak H, Guilbeau-Frugier C, Legrand-Abravanel F, Cointault O, Ribes D, et al. Hepatitis E virus and the kidney in solid-organ transplant patients. Transplantation 2012;93:617-623.
70. Kamar N, Bendall RP, Peron JM, Cintas P, Prudhomme L, Mansuy JM, et al. Hepatitis E virus and neurologic disorders. Emerg Infect Dis 2011;17:173-179.
71. Scharn N, Ganzenmueller T, Wenzel JJ, Dengler R, Heim A, Wegner F. Guillain-Barre syndrome associated with autochthonous infection by hepatitis E virus subgenotype 3c. Infection 2014;42:171-173.
72. van den Berg B, van der Eijk AA, Pas SD, Hunter JG, Madden RG, Tio-Gillen AP, et al. Guillain-Barre syndrome associated with preceding hepatitis E virus infection. Neurology 2014;82:491-497.
73. Al-Shukri I, Davidson E, Tan A, Smith DB, Wellington L, Johannessen I, Ramalingam S. Rash and arthralgia caused by hepatitis E. Lancet 2013;382:1856.
74. Deroux A, Brion JP, Hyerle L, Belbezier A, Vaillant M, Mosnier E, et al. Association between hepatitis E and neurological disorders: two case studies and literature review. J Clin Virol 2014;60:60-62.
75. Woolson KL, Forbes A, Vine L, Beynon L, McElhinney L, Panayi V, et al. Extra-hepatic manifestations of autochthonous hepatitis E infection. Aliment Pharmacol Ther 2014;40:1282-1291.
76. Kamar N, Rostaing L, Abravanel F, Garrouste C, Esposito L, Cardeau-Desangles I, et al. Pegylated interferon-alpha for treating chronic hepatitis E virus infection after liver transplantation. Clin Infect Dis 2010;50:E30-E33.
77. Kamar N, Rostaing L, Abravanel F, Garrouste C, Lhomme S, Esposito L, et al. Ribavirin therapy inhibits viral replication on patients with chronic hepatitis E virus infection. Gastroenterology 2010;139:1612-1618.
78. Haagsma EB, Riezebos-Brilman A, van den Berg AP, Porte RJ, Niesters HG. Treatment of chronic hepatitis E in liver transplant recipients with pegylated interferon alpha-2b. Liver Transpl 2010;16:474-477.
79. Debing Y, Emerson SU, Wang Y, Pan Q, Balzarini J, Dallmeier K, Neyts J. Ribavirin inhibits in vitro hepatitis E virus replication through depletion of cellular GTP pools and is moderately synergistic with alpha interferon. Antimicrob Agents Chemother 2014;58:267-273.
80. Kamar N, Izopet J, Tripon S, Bismuth M, Hillaire S, Dumortier J, et al. Ribavirin for chronic hepatitis E virus infection in transplant recipients. N Engl J Med 2014;370:1111-1120.
81. Pischke S, Hardtke S, Bode U, Birkner S, Chatzikyrkou C, Kauffmann W, et al. Ribavirin treatment of acute and chronic hepatitis E: a single-centre experience. Liver Int 2013;33:722-726.
82. Debing Y, Gisa A, Dallmeier K, Pischke S, Bremer B, Manns M, et al. A mutation in the hepatitis E virus RNA polymerase promotes its replication and associates with ribavirin treatment failure in organ transplant recipients. Gastroenterology 2014;147:1008-1011.e7; quiz, e15-e16.
83. Abravanel F, Lhomme S, Rostaing L, Kamar N, Izopet J. Protracted fecal shedding of HEV during ribavirin therapy predicts treatment relapse. Clin Infect Dis 2015;60:96-99.
84. Debing Y, Neyts J. Antiviral strategies for hepatitis E virus. Antiviral Res 2014;102:106-118.
85. Barnaud E, Rogee S, Garry P, Rose N, Pavio N. Thermal inactivation of infectious hepatitis E virus in experimentally contaminated food. Appl Environ Microbiol 2012;78:5153-5159.
86. Zhang J, Shih JW, Wu T, Li SW, Xia NS. Development of the hepatitis E vaccine: from bench to field. Semin Liver Dis 2013;33:79-88.
87. Zhang J, Zhang XF, Huang SJ, Wu T, Hu YM, Wang ZZ, et al. Long-term efficacy of a hepatitis E vaccine. N Engl J Med 2015;372:914-922.
88. Sherman KE, Terrault N, Barin B, Rouster SD, Shata MT; HIV-TR Investigators. Hepatitis E infection in HIV-infected liver and kidney transplant candidates. J Viral Hepat 2014;21:e74-e77.
89. Ditah I, Ditah F, Devaki P, Ditah C, Kamath PS, Charlton M. Current epidemiology of hepatitis E virus infection in the United States: low seroprevalence in the National Health and Nutrition Evaluation Survey. Hepatology 2014;60:815-822.
90. Engle RE, Kuniholm MH, Nelson KE, Purcell RH. Hepatitis E virus seroprevalence in the National Health and Nutrition Examination Survey: facts trump opinion. Hepatology 2015;61:1442.
91. Kuniholm MH, Engle RE, Purcell RH, Nelson KE. Hepatitis E virus seroprevalence in the United States: no easy answers. Hepatology 2015;1441-1442.
92. Wang Y, Zhou X, Debing Y, Chen K, Van Der Laan LJ, Neyts J, Janssen HL, et al. Calcineurin inhibitors stimulate and mycophenolic acid inhibits replication of hepatitis E virus. Gastroenterology 2014;146:1775-1783.
93. Zhou X, Wang Y, Metselaar HJ, Janssen HL, Peppelenbosch MP, Pan Q. Rapamycin and everolimus facilitate hepatitis E virus replication: revealing a basal defense mechanism of PI3K-PKB-mTOR pathway. J Hepatol 2014;61:746-754.